Medical Property Investment Fd Ltd
18 April 2006
For immediate release
Not for release, publication or distribution in whole or in part, in or into the
United States of America, Canada, Australia, the Republic of South Africa, Japan
or any other jurisdiction if to do so would constitute a violation of the
relevant laws of such jurisdiction
The Medical Property Investment Fund Limited
Proposed acquisition of Berrington and Placing and Open Offer
On 13 April 2006, The Medical Property Investment Fund Limited announced
Proposals, inter alia, to acquire Berrington and to raise £110.0 million before
expenses by way of a placing and open offer of 64,729,021 Open Offer Shares.
The Company now announces that the prospectus in relation to the Proposals has
been dispatched to Shareholders. The timetable of key events relating to the
Proposals is set out below:
Record Date for the Open Offer close of business on 12 April 2006
Ex-entitlement date for the Open Offer 18 April 2006
Open Offer Entitlements credited to CREST stock accounts 18 April 2006
Recommended latest time for requesting withdrawal of
Open Offer Entitlements from CREST 4.30 p.m. on 4 May 2006
Latest time for depositing Open Offer Entitlements
into CREST 3.00 p.m. on 8 May 2006
Latest time and date for splitting Application Forms
(to satisfy bona fide market claims) 11.00 a.m. on 9 May 2006
Latest time and date for receipt of Forms of Proxy 11.00 a.m. on 10 May 2006
Latest time and date for receipt of completed
Application Forms and payment in full under the
Open Offer or settlement of relevant
CREST instruction (as appropriate) 11.00 a.m. on 11 May 2006
Extraordinary General Meeting 11.00 a.m. on 12 May 2006
Admission expected to occur and dealings
expected to commence in New Ordinary Shares 8.00 a.m. on 15 May 2006
Completion of the Acquisition
(assuming all conditions are satisfied) 15 May 2006
CREST accounts credited in respect of the
New Ordinary Shares to be
issued in uncertificated form 15 May 2006
Definitive share certificates expected to
be dispatched in respect of
New Ordinary Shares in certificated form 22 May 2006
The New Ordinary Shares will, on Admission, rank in full for all dividends and
other distributions declared, made or paid on the Ordinary Shares after
Admission (save that they will not rank for the final dividend declared by the
Company for the 12 months ended 31 December 2005) and will otherwise rank pari
passu in all respects with the Ordinary Shares in issue at the date of this
announcement.
Terms and expressions used in this announcement shall, unless the context
otherwise requires, have the same meanings as given to them in the Company's
announcement of 13 April 2006.
Enquiries
Richard Burrell Berrington Fund Management Limited 020 7659 6271
Tony Langham Lansons Communications 020 7294 3617 Tonyl@lansons.com
07979 692 287
James Horsman Lansons Communications 020 7294 3686 Jamesh@lansons.com
07730 989 699
Charlotte Edgar Lansons Communications 020 7294 3622 Charlottee@lansons.com
07734 929 219
This announcement does not constitute or form part of any offer or invitation to
sell or issue, or any solicitation of any offer to acquire, purchase or
subscribe for any securities. This announcement has not been examined or
approved by the FSA or the London Stock Exchange or any other regulatory
authority. The distribution of this announcement in certain jurisdictions may
be restricted by law and therefore persons into whose possession this
announcement comes should inform themselves about and observe any such
restrictions. Any failure to comply with these restrictions may constitute a
violation of the securities laws of any such jurisdiction. Any purchase of or
application for shares in the Placing and the Open Offer should only be made on
the basis of information contained in the formal prospectus issued in connection
with the Placing and the Open Offer and any supplement thereto.
The information contained herein is not for publication or distribution in or
into the United States of America. These materials are not an offer of
securities for sale in the United States. The securities referred to herein
have not been and will not be registered under the U.S. Securities Act of 1933
(the 'Act'), as amended, and may not be offered or sold in the United States
absent registration under the Act or an available exemption from registration.
No public offering of the securities referred to herein will be made in the
United States. The information contained in this announcement is not for
publication or distribution to persons in Australia, Canada, Japan or the
Republic of South Africa. The shares referred to herein may not, directly or
indirectly, be offered, sold, taken up or delivered in, into or from Australia,
Canada, Japan or the Republic of South Africa.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.